PRECEE2 Perinatal Research
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON · Apr 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The PRECEE2 Perinatal Research trial is studying how certain environmental factors might affect pregnancy complications and outcomes for women who gave birth at Besançon University Hospital in France between 2011 and 2025. The aim is to better understand the links between these factors and any complications that may arise during pregnancy.
To be eligible for this study, women must have given birth at the hospital during the specified time and should not have any objections to their medical data being used for research. Unfortunately, women who are legally unable to participate in research or who are already involved in another study cannot take part. If eligible, participants can expect to contribute valuable information that may help improve future care for pregnant women. It's important to know that the trial is not yet recruiting participants, so it may take some time before anyone is invited to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Women who gave birth at the CHUB between 01/01/2011 and 12/31/2025
- • who have not expressed any objection to the processing of their data.
- Exclusion Criteria:
- • Legal incapacity or limited legal capacity
- • Subject is within the exclusion period of another study or is excluded from the "national volunteer file".
- • Subject refusing the collection of his/her medical data.
About Centre Hospitalier Universitaire De Besancon
The Centre Hospitalier Universitaire de Besançon (CHU de Besançon) is a leading academic medical center located in Besançon, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Besançon focuses on a wide range of medical disciplines, fostering collaboration between healthcare professionals and researchers to develop new therapeutic strategies and improve patient outcomes. With a commitment to rigorous scientific standards and ethical practices, the institution plays a vital role in translating research findings into practical applications, ultimately enhancing the quality of care provided to the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported